• Morgan Stanley Reaffirms Overweight Rating for Silence Therapeutics (NASDAQ:SLN)

    المصدر: Buzz FX / 08 أكتوبر 2024 13:36:11   America/New_York


    Morgan Stanley Reaffirms Overweight Rating for Silence Therapeutics (NASDAQ:SLN) Written by MarketBeat October 8, 2024 Share Link copied to clipboard. Silence Therapeutics ( NASDAQ:SLN - Get Free Report ) 's stock had its "overweight" ratin
    Read more...
شارك على،